[go: up one dir, main page]

AU9507698A - (lmb) gene of (streptococcus agalactiae) - Google Patents

(lmb) gene of (streptococcus agalactiae)

Info

Publication number
AU9507698A
AU9507698A AU95076/98A AU9507698A AU9507698A AU 9507698 A AU9507698 A AU 9507698A AU 95076/98 A AU95076/98 A AU 95076/98A AU 9507698 A AU9507698 A AU 9507698A AU 9507698 A AU9507698 A AU 9507698A
Authority
AU
Australia
Prior art keywords
lmb
gene
streptococcus agalactiae
agalactiae
streptococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU95076/98A
Inventor
Rudolf Lutticken
Andreas Podbielski
Eva Rozdzinski
Barbara Spellerberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of AU9507698A publication Critical patent/AU9507698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU95076/98A 1997-09-26 1998-09-25 (lmb) gene of (streptococcus agalactiae) Abandoned AU9507698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5995297P 1997-09-26 1997-09-26
US60059952 1997-09-26
PCT/US1998/020028 WO1999016882A1 (en) 1997-09-26 1998-09-25 LMB GENE OF $i(STREPTOCOCCUS AGALACTIAE)

Publications (1)

Publication Number Publication Date
AU9507698A true AU9507698A (en) 1999-04-23

Family

ID=22026372

Family Applications (1)

Application Number Title Priority Date Filing Date
AU95076/98A Abandoned AU9507698A (en) 1997-09-26 1998-09-25 (lmb) gene of (streptococcus agalactiae)

Country Status (3)

Country Link
EP (1) EP1037997A1 (en)
AU (1) AU9507698A (en)
WO (1) WO1999016882A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531054A (en) * 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Nucleic acids and proteins from group B streptococci
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
AU2008200977B2 (en) * 2000-10-27 2009-11-12 J. Craig Venter Institute, Inc. Nucleic acids and proteins from streptococcus groups A & B
EP1671981A3 (en) 2000-10-27 2006-07-05 Chiron SRL. Nucleic acids and proteins from streptococcus group A
PT1648500E (en) 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2006078318A2 (en) 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
US7838010B2 (en) 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
AU2008299376B2 (en) 2007-09-12 2013-02-28 Glaxosmithkline Biologicals S.A. GAS57 mutant antigens and GAS57 antibodies
PT2235046E (en) 2007-12-21 2012-10-26 Novartis Ag Mutant forms of streptolysin o

Also Published As

Publication number Publication date
EP1037997A1 (en) 2000-09-27
WO1999016882A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
AU6112598A (en) Single step assembly of multiple dna fragments
AU4787697A (en) Therapeutic gene
AU5183498A (en) Computer controlled gas lift system
AU1719999A (en) Insulated skull pins
AU8694898A (en) Targeted gene discovery
AU5954398A (en) Modified phytases
AU1458499A (en) Interface optimized computer system architecture
AU6729198A (en) Cosmetic preparations
AUPP032897A0 (en) Oligomer libraries
AU3737297A (en) Bacteriophage-mediated gene therapy
AU7060698A (en) Design of computer networks
AU9507698A (en) (lmb) gene of (streptococcus agalactiae)
AU2091799A (en) Uses of alpha-conotoxin peptides
AUPO554397A0 (en) Personal gaming system
AU6303898A (en) Component of bromelain
AU7094498A (en) Dummy
AU4397797A (en) Method of gene introduction
AU5498198A (en) Beta-ketoacyl-acp-synthetase ii enzyme and gene encoding the same
AU2701799A (en) Computers
AU9001898A (en) Beta-fructofuranosidase and gene thereof
AU1451200A (en) Dual reporter system and methods of use therefor
AU6659998A (en) Tazarotene-induced gene 3 (tig3)
AUPP091197A0 (en) Direct manipulation of compressed geometry
AU1702499A (en) Recognition e-circuits capable of translation-tolerant recognition
AU8999198A (en) Viral vector system capable of expressing an apoptosis-associated gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase